Telmisartan/Amlodipine 40/5 mg

Adult dose

The recommended dose of this medication is 1 tablet taken once daily, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). In cases of severe kidney impairment, treatment should start at a lower dose, and the dose should be gradually increased. For patients with liver impairment, the daily dose of telmisartan should not exceed 40 mg. Elderly patients (75 years or older) should start with a lower dose.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established, so its use is not recommended.

This drug can cause serious health issues to the fetus or newborn when taken during pregnancy, especially in the second and third trimesters, and therefore should not be taken by women who are pregnant or may become pregnant. This drug should not be administered to patients with specific diseases, such as those with severe liver or heart problems, severe hypotension, and certain genetic disorders. Patients with primary aldosteronism, heart valve disease, liver dysfunction, gastrointestinal disorders, kidney disease, the elderly, and others need special caution when using this drug. Common side effects such as dizziness or swelling may occur while taking this drug, and serious side effects can occur rarely; therefore, if any unusual symptoms arise, consult a healthcare professional immediately. This drug should not be used during pregnancy, and if pregnancy is confirmed, treatment should be discontinued as soon as possible, and alternative therapy should be sought. Hypotension may occur, so patients who are deficient in fluid or salt should adjust their condition before taking this drug and monitor their status carefully during treatment. Since there is a risk of elevated potassium levels in the blood, caution is needed if supplementing with potassium or taking medications containing potassium. Patients with decreased kidney function should have their kidney function and serum electrolyte levels monitored regularly while taking this drug. Patients with heart disease should be cautious as this drug may worsen symptoms of myocardial infarction or angina. This drug may cause drowsiness or dizziness, so extra care should be taken while driving or operating hazardous machinery during treatment. This drug may interact with other medications, so if you are taking any other medications, be sure to inform your healthcare provider. The elderly may be more sensitive to this drug, so it is safer to start at a lower dose and gradually increase. In cases of overdose, symptoms such as decreased blood pressure, dizziness, and abnormal heart rhythms may occur, and appropriate treatment should be sought immediately at a medical facility. This drug is not recommended for children as its safety and efficacy have not been established in this population. Store this medication away from children, and open the packaging immediately before taking.

Serious side effects

Severe swelling (angioedema), hives, difficulty breathing, interstitial lung disease, hepatitis, jaundice, myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, vasculitis, sepsis, anaphylactic reaction, syncope, Stevens-Johnson syndrome, photosensitivity reaction, toxic epidermal necrolysis, renal impairment (including acute renal failure), congestive heart failure, cerebral infarction, intestinal vascular edema

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light, so it should be stored in a container that protects against light and kept at room temperature between 1 and 30 degrees Celsius. Therefore, it is important to avoid direct sunlight and not to store it in excessively hot or cold places.

Appearance

Biconvex oval dual tablet in white and light blue color

Package unit

30 tablets (10 tablets/PTP x 3)